Cell Impact reports fourth quarter results: increased sales
Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the fourth quarter.· Revenues for the quarter amounted to SEK 21.0 million (8.9). Total revenues up to and including the fourth quarter amounted to SEK 81.8 million (29.3), which is growth of 179% for the entire year. · Operating result was SEK -25.7 million (-12.3). Total operating result was SEK -78.0 million up to and including the fourth quarter (-43.1). · The Group's result after financial items was SEK -26.5 million (-12.5). · Earnings per share attributable to the shareholders of the